Interstitial laser coagulation in the management of lower urinary tract symptoms suggestive of bladder outlet obstruction from benign prostatic hyperplasia: long-term follow-up

BJU Int. 2007 Jul;100(1):89-93. doi: 10.1111/j.1464-410X.2007.06863.x. Epub 2007 Apr 5.

Abstract

Objective: To evaluate the long-term effects, including durability, of interstitial laser coagulation (ILC) in patients with symptomatic benign prostatic hyperplasia.

Patients and methods: In all, 49 men (median age 68 years, range 52-80) were treated with ILC; 22 men were assessed for a median (range) of 54 (46-61) months. Information on the timing and type of re-treatment were collected for the remaining patients.

Results: The median (quartiles) International Prostate Symptom Score decreased from 22 (19-28) at baseline to 13 (5-21), a decrease of 41%. The peak urinary flow increased by 20% to 10.2 (8.7-12.9) mL/s. Twenty-two patients were re-treated (by any type) after ILC, giving a re-treatment rate of 50%.

Conclusion: There were moderate effects on voiding variables and a high re-treatment rate during the long-term follow-up after ILC. It seems reasonable that the use of ILC is restricted to selected, high-risk patients.

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Follow-Up Studies
  • Humans
  • Laser Coagulation / standards*
  • Male
  • Middle Aged
  • Prostatic Hyperplasia / complications
  • Prostatic Hyperplasia / surgery*
  • Prostatism / etiology
  • Prostatism / surgery*
  • Reoperation
  • Time Factors
  • Treatment Outcome
  • Urinary Bladder Neck Obstruction / etiology
  • Urinary Bladder Neck Obstruction / surgery*
  • Urodynamics